Lagos COVID-19 Black Seed Oil Trial (LACBSOT)

An Open-label Clinical Trial of Anti-viral Efficacy and Immune-boosting Effects of Oral Treatment with Black Seed Oil in Patients with Corona Virus Disease (COVID-19)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202007611764617

Enrollment

Registered

2020-07-07

Start date

2020-09-01

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

Black seed oil

LopinavirRitonavir

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Individuals who have been tested and confirmed to be positive Stable, not on ventilator Not having any underlining ailment males or females above 18 years.

Exclusion criteria

Exclusion criteria: Individuals already tested negative Known allergy to black seed oil, Those that have had treatment with any drugs or any other medicine in the last 2 weeks, Those who refused to give informed consent, Those with hypertension, pregnancy, breastfeeding, diabetes, asthma, hepatitis, or any other ailments Those participating in other studies at the Centre.

Design outcomes

Primary

Measure	Time frame
1. Viral load at 15 day. 2. Length of stay in the hospital	—

Secondary

Measure	Time frame
The level of inflammatory factors IL-1, IL-2, IL-6, IL-7, IL-10, granulocyte colony-stimulating factor (GCSF), interferon-gamma-induced protein (IP-10) and monocyte chemoattractant protein-1 (MCP-1)	—

Countries

Nigeria

Contacts

Public ContactHussein AbdurRazzaq

Head Health Research Unit

hussein.abdur-razzaq@lagosstate.gov.ng+2348099355417

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026